Showing results (371-380 of 413) with videos related to
Sort By:
Pageof 42
Environmental Health Perspectives|June 13, 2013
Gestational exposure of mice to secondhand cigarette smoke causes bronchopulmonary dysplasia blocked by the nicotinic receptor antagonist mecamylamineShashi P Singh, Sravanthi Gundavarapu, Kevin R Smith, et al.The Journal of Clinical Endocrinology and Metabolism|November 23, 2017
Quantitative Brain MRI in Congenital Adrenal Hyperplasia: In Vivo Assessment of the Cognitive and Structural Impact of Steroid HormonesEmma A Webb, Lucy Elliott, Dominic Carlin, et al.Diabetic Medicine : a Journal of the British Diabetic Association|October 24, 2006
Asian MODY: are we missing an important diagnosis?J R Porter, J J Rangasami, S Ellard, et al.Nature|July 22, 2014
The long-term maintenance of a resistance polymorphism through diffuse interactionsTalia L Karasov, Joel M Kniskern, Liping Gao, et al.Journal of Medicinal Chemistry|October 5, 2022
Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase InhibitorsRongjun He, Jifeng Wang, Zhi-Hong Yu, et al.Nature Communications|September 28, 2022
Activation of the human insulin receptor by non-insulin-related peptidesNicholas S Kirk, Qi Chen, Yingzhe Ginger Wu, et al.Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1', P1, and/or P3 substitutionsDavid G Barrett, John G Catalano, David N Deaton, et al.Vaccine|February 8, 2006
Immunization with fibrillar Abeta(1-42) in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain AbetaElizabeth Head, Edward G Barrett, M Paul Murphy, et al.Endocrinology|May 28, 2005
A novel glucokinase activator modulates pancreatic islet and hepatocyte functionAlexander M Efanov, David G Barrett, Martin B Brenner, et al.Bioorganic & Medicinal Chemistry Letters|December 13, 2006
Acyclic, orally bioavailable ketone-based cathepsin K inhibitorsDavid G Barrett, John G Catalano, David N Deaton, et al.Pageof 42